Comparative outcomes of lopinavir/ritonavir and hydroxychloroquine for the treatment of COVID-19 with mild-to-moderate severity: A retrospective observational study

Background Lopinavir/ritonavir (LPV/r) and hydroxychloroquine (HCQ) are both being used to treat coronavirus disease 2019 (COVID-19), but their relative effectiveness is unknown. The purpose of this study was to compare the clinical outcomes of patients treated for COVID-19 with LPV/r or HCQ. Method...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Antiviral therapy 2021-01, Vol.26 (1-2), p.34-42
Hauptverfasser:	Lee, Jeong Eun, Lee, Soon Ok, Heo, Jeonghun, Kim, Dong Wan, Park, Mi Ran, Son, Hyunjin, Kim, Dongkeun, Kim, Kye-Hyung, Lee, Shinwon, Lee, Sun Hee
Format:	Artikel
Sprache:	eng
Schlagworte:	Coronaviruses COVID-19 COVID-19 - drug therapy HIV Infections - drug therapy Humans Hydroxychloroquine Hydroxychloroquine - therapeutic use Lopinavir Lopinavir - therapeutic use Observational studies Patients Ritonavir
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!